new version V2017

insulin sensitizers - PPAR modulator
Description Results

     

  • Group by...

TrialStudied treatmentControl treatmentpatientsROBResultNCT

diabetes type 2

aleglitazar
ALECARDIOaleglitazarplacebo - NCT01042769
BC20265 ongoing aleglitazaractos - NCT00461058
BC22140 ongoing aleglitazarplacebo - NCT01042769



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons